Tech Company Financing Transactions

Arrakis Therapeutics Funding Round

Arrakis Therapeutics, operating out of Waltham, secured $75 million from Nextech Invest, venBio and Advent Life Sciences.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B

Nextech Invest (Lead Investor) (Jakob Loven)

venBio (Lead Investor) (Richard Gaster)

Advent Life Sciences (Raj Parekh)

Alexandria Venture Investments

Canaan Partners (Colleen Cuffaro)

Celgene (Russell Petter)


HBM Healthcare Investments

private investors (Henri Termeer)

Omega Funds

Osage Partners (Matthew Cohen)

Pfizer Venture Investments

WuXi AppTec

Proceeds Purpose
With this financing and outstanding syndicate of investors, Arrakis will leap to the next stage of realizing our vision of creating a new class of medicines with RNA-targeted small molecules, or rSMs.

Company Information

Company Status
Private & Independent
Mailing Address
830 Winter St.
Waltham, MA 02451
Email Address
The therapeutic potential of the human transcriptome, the set of all RNAs transcribed from DNA, remains largely unexplored. By harnessing new insights into RNA structure and dynamics, Arrakis is opening the transcriptome to therapy by small-molecule medicines to treat patients not cured by today's medicines.
Arrakis Therapeutics LinkedIn Company Profile
Social Media
Arrakis Therapeutics Company Twitter Account
Company News
Arrakis Therapeutics News
Arrakis Therapeutics on Facebook
Arrakis Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Michael Gilman
  Michael Gilman LinkedIn Profile  Michael Gilman Twitter Account  Michael Gilman News  Michael Gilman on Facebook
Chief Scientific Officer
Russell Petter
  Russell Petter LinkedIn Profile  Russell Petter Twitter Account  Russell Petter News  Russell Petter on Facebook
Vice President
James Barsoum
  James Barsoum LinkedIn Profile  James Barsoum Twitter Account  James Barsoum News  James Barsoum on Facebook
Vice President
Gnanasambandam Kumaravel
  Gnanasambandam Kumaravel LinkedIn Profile  Gnanasambandam Kumaravel Twitter Account  Gnanasambandam Kumaravel News  Gnanasambandam Kumaravel on Facebook
VP - Bus. Development
Daniel Koerwer
  Daniel Koerwer LinkedIn Profile  Daniel Koerwer Twitter Account  Daniel Koerwer News  Daniel Koerwer on Facebook
VP - Operations
Heather Lounsbury
  Heather Lounsbury LinkedIn Profile  Heather Lounsbury Twitter Account  Heather Lounsbury News  Heather Lounsbury on Facebook



Browse more venture capital transactions:

Prev: 4/19/2019: Phantom AI venture capital transaction
Next: 4/19/2019: Viome venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary